Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy ...

Authors: Katrin Rupalla, Michel Janicot, Alexej Schmidt, Iris Helfrich, Bernhard B. Singer

Full Title: Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy, and significantly increases tumor-associated B-cell population in syngeneic liver Hepa1-6 tumor microenvironment

This poster was presented at the SITC 2022.

SITC poster_final

.pdf

Download PDF • 2.43MB